Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CFSAN AE Monitoring System To Receive $2.5 Mil., Contractor Help - Levitt

This article was originally published in The Tan Sheet

Executive Summary

The Center for Food Safety & Applied Nutrition's Adverse Event Monitoring System will be supported by approximately $2.5 mil. in FY 2000 funding as well as by an outside contractor in the process of being hired, center Director Joseph Levitt testified at a May 27 House Government Reform Committee hearing on CFSAN's monitoring of dietary supplements.

You may also be interested in...



Capitol Hill Lawmakers Could Revisit Pearson, DSHEA In 2001

Congressional leaders may be looking to the 107th Congress to initiate hearings on FDA's actions in implementing the Pearson v. Shalala decision.

Capitol Hill Lawmakers Could Revisit Pearson, DSHEA In 2001

Congressional leaders may be looking to the 107th Congress to initiate hearings on FDA's actions in implementing the Pearson v. Shalala decision.

Capitol Hill Lawmakers Could Revisit Pearson, DSHEA In 2001

Congressional leaders may be looking to the 107th Congress to initiate hearings on FDA's actions in implementing the Pearson v. Shalala decision.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089865

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel